Evidence map›Paper›PMID 33231685›Full record

ArticleNucleic acids research2021

Customized optical mapping by CRISPR-Cas9 mediated DNA labeling with multiple sgRNAs.

Heba Z Abid, Eleanor Young, Jennifer McCaffrey, Kaitlin Raseley, Dharma Varapula, Hung-Yi Wang, Danielle Piazza, Joshua Mell, Ming Xiao

Abstract readComparative Study
In one paragraph

Article in Nucleic acids research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Mechanisms regulating the CRISPR-Cas systems.Frontiers in microbiology · 2023
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Heba Z AbidSchool of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, PA, USA.
Eleanor YoungSchool of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, PA, USA.
Jennifer McCaffreySchool of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, PA, USA.
Kaitlin RaseleySchool of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, PA, USA.
Dharma VarapulaSchool of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, PA, USA.
Hung-Yi WangSchool of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, PA, USA.
Danielle PiazzaSchool of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, PA, USA.
Joshua MellDepartment of Microbiology and Immunology, College of Medicine, Drexel University, Philadelphia, PA, USA.
Ming XiaoSchool of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, PA, USA.

Funding

Single molecule DNA mapping for genome and CNV analysisR01HG005946 · NHGRI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KWOK, PUI-YAN, XIAO, MING · 2010 to 2021
$6.5M
NHGRI NIH HHS R01 HG005946
6 · The paper itself

Abstract

Whole-genome mapping technologies have been developed as a complementary tool to provide scaffolds for genome assembly and structural variation analysis (1,2). We recently introduced a novel DNA labeling strategy based on a CRISPR-Cas9 genome editing system, which can target any 20bp sequences. The labeling strategy is specifically useful in targeting repetitive sequences, and sequences not accessible to other labeling methods. In this report, we present customized mapping strategies that extend the applications of CRISPR-Cas9 DNA labeling. We first design a CRISPR-Cas9 labeling strategy to interrogate and differentiate the single allele differences in NGG protospacer adjacent motifs (PAM sequence). Combined with sequence motif labeling, we can pinpoint the single-base differences in highly conserved sequences. In the second strategy, we design mapping patterns across a genome by selecting sets of specific single-guide RNAs (sgRNAs) for labeling multiple loci of a genomic region or a whole genome. By developing and optimizing a single tube synthesis of multiple sgRNAs, we demonstrate the utility of CRISPR-Cas9 mapping with 162 sgRNAs targeting the 2Mb Haemophilus influenzae chromosome. These CRISPR-Cas9 mapping approaches could be particularly useful for applications in defining long-distance haplotypes and pinpointing the breakpoints in large structural variants in complex genomes and microbial mixtures.

Indexed as

CRISPR-Cas SystemsAllelesBase SequenceBenzoxazolesChromosome MappingChromosomes, BacterialComputer SimulationConserved SequenceDNA-Directed RNA PolymerasesDrug Resistance, BacterialFluorescent DyesGene EditingGenome, BacterialGenome, HumanHaemophilus influenzaeHaplotypes1,1'-((4,4,7,7-tetramethyl)-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-oxazole)-2-methylidene)quinoliniumbacteriophage T7 RNA polymeraseBenzoxazolesDNA-Directed RNA PolymerasesFluorescent DyesNalidixic AcidNovobiocinQuinolinium CompoundsRNA, Guide, CRISPR-Cas SystemsViral Proteins

Identifiers

PMID33231685
PMCPMC7826249

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.